Adaptive Biotechnologies (ADPT) President and COO Sells 57,180 Shares in Open-Market Transactions
Adaptive Biotechnologies (ADPT) President and COO Julie Rubinstein sold 57,180 shares of the company's stock between April 14 and 16, 2026, at an average price of $14.45 per share. The transaction involved the exercise of stock options and immediate sale of the resulting shares, reducing her direct ownership by 12.29% to 408,160 shares. The sale has raised questions about its implications for Rubinstein's future transactions and ongoing economic exposure to the company.
Tickers: $ADPT
Topics: corporate governance executive share sales SEC filings stock liquidity